Association between [18F]fluorodeoxyglucose uptake and prognostic parameters in breast cancer
Open Access
- 21 January 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 96 (2), 166-170
- https://doi.org/10.1002/bjs.6459
Abstract
Background: This study analysed the correlation between [18F]fluorodeoxyglucose (FDG) uptake assessed by positron emission tomography (PET) in breast tumours, and histopathological and inmunohistochemical prognostic factors. Methods: FDG–PET was performed before surgery in 275 women with primary breast cancer. The standarized uptake value (SUV) was compared with histopathological findings after surgery. Results: A positive relationship was found between the SUV and tumour size (r = 0·46, P < 0·001), axillary lymph node status (P < 0·001), histological type (P < 0·001), histological grade (P < 0·001), oestrogen receptor status (P < 0·001), p53 (P < 0·001) and Ki‐67 (P < 0·001) expression. Multivariable linear regression showed that tumour size, histological grade, Ki‐67 expression, oestrogen receptor status and histological type were significantly related to the SUV. Conclusion: The SUV is a preoperative and non‐invasive metabolic factor that relates to some prognostic factors in breast cancer. Copyright © 2009 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.This publication has 12 references indexed in Scilit:
- Clinicopathological and Prognostic Relevance of Uptake Level using 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) in Primary Breast CancerJapanese Journal of Clinical Oncology, 2008
- Comparison of triple‐negative and estrogen receptor‐positive/progesterone receptor‐positive/HER2‐negative breast carcinoma using quantitative fluorine‐18 fluorodeoxyglucose/positron emission tomography imaging parametersCancer, 2007
- Preoperative evaluation of prognosis in breast cancer patients by [ 18 F]2-Deoxy-2-fluoro-D-glucose-positron emission tomographyZeitschrift für Krebsforschung und Klinische Onkologie, 2004
- FDG uptake in breast cancer: correlation with biological and clinical prognostic parametersEuropean Journal of Nuclear Medicine and Molecular Imaging, 2002
- Biologic Correlates of 18Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission TomographyJournal of Clinical Oncology, 2002
- Breast Imaging With Positron Emission Tomography and Fluorine-18 Fluorodeoxyglucose: Use and LimitationsJournal of Clinical Oncology, 2000
- Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer.European Journal of Nuclear Medicine and Molecular Imaging, 1999
- Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoro[18F]-D-glucoseCancer, 1998
- Positron emission tomography and breast masses: Comparison with clinical, mammographic, and pathological findingsAnnals of Surgical Oncology, 1994
- Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET.Radiology, 1993